Patrick Conway, MD, MSc, will leave his position as the deputy administrator for Innovation and Quality at CMS and the director of the Center for Medicare and Medicaid Innovation to lead Blue Cross and Blue Shield of North Carolina (Blue Cross NC).
Patrick Conway, MD, MSc, will leave his position as the deputy administrator for Innovation and Quality at CMS and the director of the Center for Medicare and Medicaid Innovation to lead Blue Cross and Blue Shield of North Carolina (Blue Cross NC).
Conway has served in CMS since 2011, when he became the chief medical officer. He will join Blue Cross NC as the president and CEO-elect on October 1, taking over for current President and CEO Brad Wilson, who is retiring.
“Blue Cross NC’s role in transforming the healthcare system in North Carolina is a model that other plans aspire to and that I want to work with the Blue Cross NC team to further improve,” Conway said in a statement. “I look forward to collaborating with Blue Cross NC employees, healthcare providers, and employers to deliver the best health outcomes and best service experience at the lowest cost for our customers.”
Conway has been heavily involved in CMS’ efforts to transition to value-based care. During a 2016 speech at the fall meeting of the National Association of Accountable Care Organizations, Conway highlighted the increased alignment he has seen between Medicare and private payers. During his tenure, CMS set out to reach a goal of having 30% of Medicare payments under alternative payment models and 85% of all Medicare fee-for-service payments in some type of value-based arrangement by the end of 2016. Both of those goals were reached nearly a full year early.
“I think we see the pace of payment reform moving quickly right now,” Conway said in an interview with The American Journal of Managed Care® at AcademyHealth’s 2016 National Health Policy Conference. “I think the shift to alternative payment models, where providers are accountable for quality and total cost of care, has moved more in the last 3 years than we’ve ever seen before.”
His biggest concern had been maintaining the pace of payment reform and scaling successes to the rest of the country. Frank Holding, Jr, chair of the Blue Cross NC board of trustees, said Conway’s experiences as both a practicing pediatrician and a leader of CMS will help the company improve the health and well-being of its customers.
“At this important time in healthcare and health insurance transformation, Dr Conway brings a unique background and perspective to our company and state,” said Wilson, who will remain as CEO for an undetermined period to ensure an effective transition. “I look forward to working with him, and introducing him and his family to the great state of North Carolina.”
Neurologists Share Tips for Securing Patient Access to Gene Therapies
March 19th 2025Tenacious efforts at every level, from the individual clinician to the hospital to the state to Congress, will be needed to make sure patients can access life-saving gene therapies for neuromuscular diseases.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
The Impact of Cost Sharing on High-Value Care
March 14th 2025Michael Chernew, PhD, professor of health care policy and director of the Healthcare Markets and Regulation Lab, Harvard Medical School, shares how cost-sharing policies shape access to critical health care services and influence value-based insurance design.
Read More